Evidence map›Paper›PMID 37586346›Full record

ArticleCardiology2023

Patterns of Aortic Valve Replacement in Europe: Adoption by Age.

Tanja Rudolph, Clare Appleby, Victoria Delgado, Helene Eltchaninoff, Catherine Gebhard, Christian Hengstenberg, Wojtek Wojakowski, Nathan Petersen, Jana Kurucova, Peter Bramlage and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Impact of Anticoagulation on Valve Hemodynamics Following Transcatheter Valve-In-Valve Implantation.Journal of the Society for Cardiovascular Angiography & Interventions · 2026
    Article
  5. Article
  6. Article
  7. Bicuspid Aortic Valve dilemma: TAVI or SAVR? Insights from the NOTION-2 trial.Indian journal of thoracic and cardiovascular surgery · 2024
    Article
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Tanja RudolphGeneral and Interventional Cardiology/Angiology, Heart and Diabetes Centre Nord Rhine-Westphalia, University Hospital of the Ruhr University Bochum, Bad Oeynhausen, Germany.
Clare ApplebyCardiology, Liverpool Heart and Chest Hospital, Liverpool, UK.
Victoria DelgadoHeart Institute, Department of Cardiology, Hospital University Germans Trias I Pujol Barcelona, Badalona, Spain.
Helene EltchaninoffDepartment of Cardiology, Normandie University, UNIROUEN, U1096, CHU Rouen, Rouen, France.
Catherine GebhardDepartment of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Christian HengstenbergDivision of Cardiology, Department of Medicine II, Medical University of Vienna, Vienna, Austria.
Wojtek WojakowskiDivision of Cardiology and Structural Heart Diseases, Medical University of Silesia in Katowice, Katowice, Poland.
Nathan PetersenEdwards Lifesciences, Nyon, Switzerland.
Jana KurucovaMedical Affairs, Edwards Lifesciences, Prague, Czechia.
Peter BramlageInstitute for Pharmacology und Preventive Medicine, Cloppenburg, Germany, submission@ippmed.de.
Sabine BleizifferDepartment of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center North Rhine-Westphalia, University Hospital, Ruhr-University Bochum, Bad Oeynhausen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe management of patients with severe aortic stenosis may differ according to patients' age. The aim of this analysis was to describe patterns of aortic valve replacement (AVR) use in European countries stratified by age.

methodsProcedure volume data for AVR, including surgical aortic valve replacement (sAVR) and transcatheter aortic valve implantation (TAVI), for the years 2015-2020 were obtained from national databases for twelve European countries (Austria, the Czech Republic, Denmark, England, Finland, France, Germany, Norway, Poland, Spain, Sweden, and Switzerland). Procedure volumes were reported by patient age (<50 years, 5-year age groups between 50 and 85 years, and ≥85 years). Patients per million (PPM) population undergoing AVR each year were calculated using population estimates from Eurostat.

resultsAVR PPM varied widely between countries, from 508 PPM in Germany to 174 PPM in Poland in 2020. TAVI rates ranged from 61% in Switzerland and Finland to 25% in Poland. AVR PPM increased with age to a peak at 80-84 years, after which it decreased again. AVR procedures increased from 2015 to 2019 at an average annual rate of 3.9%. AVR increased more substantially in people aged ≥80 years than in younger age groups; these older age groups accounted for 30% of all AVR procedures in 2015 and 35% in 2019. TAVI accounted for an increasing proportion of all AVR procedures as patient age increased; an overall average of 96% of males and 98% of females aged ≥85 years received TAVI as the treatment modality, although adoption of TAVI differed between countries.

conclusionsThere is considerable variation in the rates of AVR use and the adoption of TAVI versus sAVR between European countries. The use of TAVI has increased in recent years, particularly for older patients.

Indexed as

Aortic Valve StenosisHeart Valve Prosthesis ImplantationTranscatheter Aortic Valve ReplacementAgedAortic ValveEuropeFemaleHumansMaleRisk FactorsTreatment OutcomeAgeAortic valve replacementEuropeTranscatheter aortic valve implantation

Identifiers

PMID37586346

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.